AMRAD CORPORATION LIMITED

AMRAD

PHARMACEUTICAL PREPARATIONS FOR HUMAN AND VETERINARY USE IN THE TREATMENT OF BLOOD DISORDERS, VIRAL DISEASE, NERVOUS SYSTEM DISFUNCTION, CANCER, BONE DISEASE, LIVER DISEASE, CARDIAC DISORDERS, INFERTILITY, PREGNANCY DISORDERS AND INFLAMMATION; ELISA KITS COMPRISED OF MICROTITRE PLATES COATED WITH ANTIGEN OR ANTIBODY, POSITIVE SERUM CONTROL, NEGATIVE SERUM CONTROL, SPECIMEN DILUENT, BIOTIN ANTIBODY CONJUGATES, BIOTIN ANTIBODY DILUENTS, STREPTAVIDIN HRPO CONJUGATES, STREPTAVIDIN HRPO DILUENTS, SUBSTRATES, BUFFER SOLUTIONS, WASH BUFFERS, STOPPING SOLUTIONS AND PLATE SEALERS FOR THE DETECTION OF AUTOIMMUNE DISEASE, MICROBIAL DISEASE, PROTEIN LEVELS, GENETIC ABNORMALITIES AND PATHOGENS;CHEMICAL PRODUCTS USED IN INDUSTRY AND SCIENCE; NAMELY, PROTEINACEOUS REAGENTS FOR USE IN MAINTAINING EMBRYOS IN CULTURE, INCREASING EMBRYO IMPLANTATION, AND CAPTURE AND ISOLATION OF DNA; MOLECULAR BIOLOGICAL REAGENTS FOR USE IN THE DETECTION OF NUCLEIC ACID SEQUENCES IN-VITRO AND FOR THE EXPRESSION, ISOLATION AND DETECTION OF RECOMBINANT PROTEINS;

AMRAD

detection of recombinant proteins; and antibody reagents and antibodies for use in detecting autoimmune disease, microbial disease, protein levels, genetic abnormalities and pathogens;

AMRAD

Pharmaceutical preparations for human and veterinary use in the treatment of blood disorders, viral disease, nervous system dysfunction, cancer, bone disease, liver disease, cardiac disorders, infertility, pregnancy disorders and inflammation; Elisa kits comprised of microtitre plates coated with antigen or antibody, positive serum control, negative serum control, specimen diluent, biotin antibody conjugates, biotin antibody diluents, streptavidin HRPO conjugates, streptavidin HRPO diluents, substrates, buffer solutions, wash buffers, stopping solutions and plate sealers for the detection of auto-immune disease, microbial disease, protein levels, genetic abnormalities and pathogens;Chemical products used in industry and science, namely, proteinaceous reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA; molecular biological reagents for use in the detection of nucleic acid sequences in-vitro and for the expression and isolation; detection of recombinant proteins; and antibody reagents and antibodies for use in detecting auto-immune disease, microbial disease, protein levels, genetic abnormalities and pathogens;

AMRAD

In the statement, Column 2, line 12, after NAMELY, CONDUCTING CLINICAL TRIALS; BIOTECHNOLOGY should be inserted.;Medical and clinical medical reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro; pharmaceutical preparation for human and veterinary use in the treatment of blood disorders, viral disease and nervous system dysfunction, cancer, bone disease, liver disease, cardiac disorders, infertility, pregnancy disorders, and inflammation; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology;chemical preparations for scientific and research use, namely, proteinaceous reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA; reagents for scientific or medical research use, namely, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro and for the expression, isolation and detection of recombination; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use in detecting auto immune disease, microbial disease, protein levels, genetic abnormalities, and pathogens;Medical testing; pharmaceutical advice;Product research and development in the field of drug discovery; research and development for new products for others in the field of drug discovery; medical and scientific research, namely, * conducting clinical trials; biotechnology * consultation and research; pharmaceutical drug development services;

CAPTAGENE

diagnostic kits consisting primarily of a support including a plate, film, disc, sheet or dip-stick coated or impregnated with DNA binding reagents; namely, DNA sequence specific binding proteins, specimen diluents and washing solutions; namely, distilled water, saline, buffers and detergent-containing solutions and/or reagents for selectively isolating, capturing and hence, detecting DNA sequences of interest; namely, DNA binding compounds including avadin or biotin conjugated to a reporter group; namely, an enzyme which produces a color change or other detectable reaction on incubation with an appropriate substrate; and diagnostic reagents for the detection of amplified DNA;

HEL-PTEST

immunological assay kit for the detection of helicobacter pylori organisms; namely, a support, a plate, film, disc, sheet or dip-stick, coated or impregnated with antigens of helicobacter pylori; specimen diluents and washing solutions; namely, distilled water, saline, buffers, detergent containing solutions; reagents for detecting helicobacter pylori organisms; diagnostic reagents for the detection of helicobacter pylori organisms;

HEL-PTEST

Immunological assay kit for the detection of helicobacter pylori organisms, namely, a support, a plate, film, disc, sheet or dip-stick, coated or impregnated with antigens of helicobacter pylori; specimen diluents and washing solutions, namely, distilled water, saline, buffers, detergent containing solutions; reagents for detecting helicobacter pylori organisms; diagnostic reagents for the detection of helicobacter phylori organisms;HELP TEST;